Aortic valve stenosis: fatal natural history despite normal left ventricular function and low invasive peak-to-peak

Kent Lodberg Christensen1, Hanne Ramløv Ivarsen, Leif Thuesen

  • 1Department of Cardiology B, University Hospital of Aarhus, Skejby Sygehus, Aarhus N, Denmark.

Cardiology
|August 31, 2004
PubMed

Insights

The peak-to-peak gradient is not a reliable indicator for aortic stenosis (AS) valve replacement decisions. A low gradient can still signify severe AS, even with normal left ventricular function, impacting patient outcomes.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Valvular Heart Disease

Background:

  • Historically, cardiac catheterization and its derived peak-to-peak gradient were central to assessing valvular aortic stenosis (AS) severity.
  • Decisions for aortic valve replacement (AVR) often relied heavily on this invasive pressure measurement and left ventricular function.

Purpose of the Study:

  • To compare the diagnostic accuracy and reproducibility of cardiac catheterization, transthoracic echocardiography (TTE), and transesophageal echocardiography (TEE) for AS evaluation.
  • To refine the strategy for managing patients with AS, particularly concerning AVR decisions.

Main Methods:

  • A prospective study involving 150 consecutive AS patients from 1994-1997.
  • Systematic assessment using cardiac catheterization, TTE, and TEE.
  • Follow-up evaluation of patient outcomes based on treatment decisions.

Main Results:

  • TTE, TEE, and cardiac catheterization demonstrated similar accuracy and reproducibility in determining aortic valve area.
  • Relying on TTE for management aligns with current recommendations due to its speed and patient comfort.
  • 12 patients with low peak-to-peak gradients (<50 mm Hg) but significant valve area reduction and symptoms were denied AVR, leading to adverse outcomes including death and worsening heart failure.

Conclusions:

  • The peak-to-peak gradient should not be a primary factor in deciding on AVR for AS patients.
  • A low peak-to-peak gradient does not rule out severe AS, even with preserved left ventricular function.
  • Current guidelines favoring TTE for AS assessment are supported by this study's findings.

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...